IM Cannabis Corp (IMCC)
NASDAQ:IMCC
Want to see IMCC full AI Analyst Report?
IMCC Stock Chart & Stats
$1.44
-$0.13(-4.96%)
At close: 4:00 PM EST
$1.44
-$0.13(-4.96%)
Day’s Range― - ―
52-Week Range$0.12 - $3.75
Previous Close$2.49
Volume28.72K
Average Volume (3M)72.27K
Market Cap
$878.11K
Enterprise Value$32.03M
Total Cash (Recent Filing)$1.15M
Total Debt (Recent Filing)$14.95M
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-282.07
Shares Outstanding6,223,323
10 Day Avg. Volume74,089
30 Day Avg. Volume72,265
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-9.42
Price to Sales (P/S)0.15
P/FCF Ratio1.72
Enterprise Value/Market Cap36.47
Enterprise Value/Revenue0.73
Enterprise Value/Gross Profit4.42
Enterprise Value/Ebitda-6.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$62.75M
Bulls Say, Bears Say
Bulls Say
Strong Germany Market PositionIMC’s EU-GMP-certified platform and 134% Germany sales surge demonstrate durable market access and scale in Europe’s largest medical cannabis market. This concentration provides distribution strength, regulatory qualification advantages and potential long-term revenue base as Germany’s medical market expands.
Prior Cash-flow Turnaround And Margin ImprovementThe 2025 operating cash-flow positive result and meaningful margin pickup indicate the business can reach cash generation with the right sales scale and cost controls. These operational improvements are durable levers that can support reinvestment or deleveraging if sustained across quarters.
Planned Divestiture To Reduce Debt And Refocus OperationsA contemplated sale that would shift C$10.5M of liabilities off the balance sheet signals active deleveraging and strategic focus on core Israeli operations. If completed, this structural move could improve leverage, free cash flow prospects and management bandwidth for higher-return markets.
Bears Say
Negative Shareholders' Equity And Elevated DebtNegative equity and ~ $15M of debt materially reduce financial flexibility and increase refinancing and covenant risk. Distorted leverage metrics limit access to traditional financing, constrain strategic options, and elevate the likelihood that future growth will require dilutive capital solutions.
Sustained Operating Losses And Revenue DeclineOngoing top-line contraction and multi-year operating losses indicate the cost base still outstrips scale. Even with margin gains, persistent negative EBITDA and net losses undermine internal funding capability, lengthen the path to self-sustaining operations, and increase reliance on external capital.
Reliance On Convertible Financings And Dilution RiskRepeated convertible note financings and resale registrations show dependence on equity-linked capital to fund operations. This creates persistent dilution risk and share overhang, which can erode long-term shareholder value and signal constrained access to non-dilutive funding sources.
IM Cannabis Corp News
IMCC FAQ
What was IM Cannabis Corp’s price range in the past 12 months?
IM Cannabis Corp lowest stock price was $0.12 and its highest was $3.75 in the past 12 months.
What is IM Cannabis Corp’s market cap?
IM Cannabis Corp’s market cap is $878.11K.
When is IM Cannabis Corp’s upcoming earnings report date?
IM Cannabis Corp’s upcoming earnings report date is Aug 17, 2026 which is in 51 days.
How were IM Cannabis Corp’s earnings last quarter?
IM Cannabis Corp released its earnings results on May 13, 2026. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.28.
Is IM Cannabis Corp overvalued?
According to Wall Street analysts IM Cannabis Corp’s price is currently Overvalued.
Does IM Cannabis Corp pay dividends?
IM Cannabis Corp does not currently pay dividends.
What is IM Cannabis Corp’s EPS estimate?
IM Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IM Cannabis Corp have?
IM Cannabis Corp has 6,223,323 shares outstanding.
What happened to IM Cannabis Corp’s price movement after its last earnings report?
IM Cannabis Corp reported an EPS of -$0.28 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.187%.
Which hedge fund is a major shareholder of IM Cannabis Corp?
Currently, no hedge funds are holding shares in IMCC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IM Cannabis Corp
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Technical Analysis
Ownership Overview
23.24% Insiders
0.23% Other Institutional Investors
76.53% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---